A SIMPLE KEY FOR HEMGENIX UNVEILED

Number of eligible people: CDEC talked over the uncertainty in the amount of patients with reasonably intense to severe hemophilia B in Canada suitable for etranacogene dezaparvovec. Scientific industry experts consulted by CADTH indicated that some people who will be classified as having moderate or reasonable ailment could have a extreme bleeding